A single infusion of a CRISPR-based gene therapy eliminated painful crises in 27 of 28 patients with severe sickle cell ...

Under an FDA ruling that expands access to clinical trials, HonorHealth Research Institute is one of the first in the nation ...

The radiologist completed a two-year mental health diversion program, ending the high-profile case, prosecutors said.

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) could see increased investor attention as it approaches Phase IIb data for its oral DMT-based therapy VLS-01, according to Jefferies analysts, who highlighted ...

TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), addressing the immunological drivers at the source of IgA ...

Fort Smith National Historic Site will commemorate the 130th anniversary of Cherokee Bill's execution with a trial reenactment, symposium and tours.

Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-to-clinic journey in Nature Biotechnology, and ...

Organon Dermatology to present new Phase 3 analysis of VTAMA eczema data at the Society for Pediatric Dermatology annual meeting on July 23, 2026.

Clinical Program Advances Following Favorable Safety Review; Peer-Reviewed Publication Further Validates Deciparticle™ Platform ...

A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...

An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...